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Abstract Both melatonin and its precursor N-acetylserotonin
have been reported to exert antioxidant properties both in vitro
and in vivo. Since little is known about their antioxidant activity
in lymphocytes, we investigated their effects on spontaneous and
on oxidant-induced reactive oxygen species formation in human
peripheral blood lymphocytes in comparison to the antioxidant
trolox, a water-soluble analogue of K-tocopherol. Both melatonin
and N-acetylserotonin exhibited antioxidant properties against
t-butylated hydroperoxide- and diamide-induced reactive oxygen
species formation in peripheral blood lymphocytes. N-acetylsero-
tonin turned out to be about three times more effective than
melatonin. In resting cells, the intracellular reactive oxygen
species concentration was only decreased by N-acetylserotonin
and trolox, melatonin had no effect. In t-butylated hydroper-
oxide-mediated cell death, N-acetylserotonin was as effective as
trolox in protecting peripheral blood lymphocytes from cell death
and required 10-fold lower concentrations than melatonin.
Furthermore, in an aqueous cell-free solution, the capacity of
N-acetylserotonin to scavenge peroxyl radicals was much higher
than that of melatonin. These results clearly indicate N-
acetylserotonin to be a much better antioxidant than melatonin.
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1. Introduction
Melatonin (MEL), the chief secretory product of the pineal
gland, has been claimed to exhibit distinct antioxidant fea-
tures in vitro as well as in vivo (for review see [1]). Since
MEL was described to be a more e¡ective scavenger of per-
oxyl and hydroxyl radicals than K-tocopherol and glutathione
[2,3], it was postulated to be an essential element of the mam-
malian antioxidant defense system and to exert its physiolog-
ical e¡ects at least in part via in£uencing the cellular redox
status [4]. Because of its low toxicity, MEL was considered to
have therapeutic implications in deferring aging processes
[5,6], where reactive oxygen species (ROS) are known to
play an important pathogenetic role [7]. More recent studies,
however, point to a rather limited direct antioxidant potency
of MEL: to some extent it can scavenge hydroxyl [8] and
peroxyl radicals [3], but not the less reactive superoxide anion
[9]. A recent study has demonstrated that MEL acts as a
retarder of the lipid peroxidation but not as a chain-breaking
antioxidant [10]. This is consistent with results from lipid per-
oxidation assays, where the antioxidant capacity of MEL was
much lower than that of K-tocopherol [11,12] and required
markedly supraphysiological concentrations [13].
Indoleamines in general are known to in£uence biological
oxidation processes [14] and N-acetylserotonin (NAS), the im-
mediate precursor as well as a major product of in vivo back-
transformation of MEL, has been reported to exert antioxi-
dative properties [15,16,17]. To further di¡erentiate the role
and the physiological signi¢cance of MEL in the cellular anti-
oxidant defense system, it was the aim of the present study to
clarify the radical scavenging potency of MEL in comparison
to NAS and the well-characterized antioxidant trolox (TX), a
water-soluble analogue of K-tocopherol. Since little is known
about antioxidant activities of MEL and NAS in lympho-
cytes, which are sensitive to oxidative stress [18,19], we inves-
tigated their e¡ects on the spontaneous and oxidant-induced
ROS formation, as well as on the ROS induced cell death in
human peripheral blood lymphocytes (PBL).
2. Materials and methods
If not otherwise speci¢ed, substances were purchased from Sigma
(St. Louis, MO, USA) and were of analytical grade or better. Dihy-
drorhodamine (DHR) was purchased from Molecular Probes (Eu-
gene, OR, USA). 2,2P-azobis (amidinopropane hydrochloride)
(AAPH) was obtained from Polysciences (Warrington, PA, USA).
2.1. Isolation of lymphocytes
Peripheral blood lymphocytes (PBL) from venous blood of healthy
adult male donors were obtained by Ficoll-Hypaque gradient centri-
fugation. Isolated PBL were washed three times with PBS (10 mM
sodium phosphate, 160 mM NaCl, pH = 7.4) and ¢nally suspended in
RPMI 1640 (PAA Laboratories, Exton, USA) plus 10% fetal calf
serum (FCS, PAA Laboratories, Exton, USA) at a concentration of
1U106 cells/ml. Cells were then stimulated with the mitogen conca-
navalin A (Con A, 5 Wg/ml) for 72 h, washed three times with PBS
and cultured in RPMI 1640/10% FCS and 10 U/ml recombinant hu-
man interleukin-2 (IL-2, Boehringer Mannheim, Germany) at a con-
centration of 1U106 cells/ml. Medium and IL-2 were replaced every
two days. For the experiments, activated PBL from day ¢ve to day 11
after stimulation were taken. The cell viability as determined with the
trypan blue exclusion test was s 95%.
2.2. Determination of ROS formation
Formation of ROS was monitored using the oxidation sensitive dye
DHR, the uncharged and non-£uorescent reduction product of the
cationic £uorescent dye rhodamine 123, which is suitable for ROS
measurements in aqueous solutions [20]. In cellular systems, this dye
passively di¡uses across cell membranes and is oxidized within the cell
to rhodamine, which is then located in the mitochondria. Thus, it is a
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useful tool for the detection of intracellular ROS formation as well
[21].
2.2.1. Monitoring of the rhodamine £uorescence in an aqueous sol-
ution. 10 WM DHR (20 mM stock solution in dimethyl-sulfoxide
(DMSO)) in PBS was incubated at 37‡C. The ROS-induced rhod-
amine £uorescence was continuously monitored at 500 nm/560 nm
(excitation/emission) after the addition of 1 mM AAPH as a radi-
cal-generating system using a Perkin-Elmer LS50-B spectro£uorime-
ter. The e¡ect of MEL and NAS at the ¢nal concentration indicated
(all solutions adjusted to a ¢nal concentration of 0.5% ethanol, re-
quired for the initial dispersion of MEL and NAS) on the peroxyl
radical-induced oxidation was determined. Pure solvent (0.5% etha-
nol) was used as a negative control.
2.2.2. Monitoring of the rhodamine £uorescence in PBL. PBL
(2U106 cells/ml) were incubated at 37‡C in the presence of 2 WM
DHR (20 mM stock solution in DMSO) for 10 min. After washing
with PBS, cells were resuspended in RPMI (1U106 cells/ml) and left
untreated or were incubated with 100 WM t-butylhydroperoxide
(t-BHP), which forms peroxyl- and alkoxyl radicals in the presence
of traces of transition metal ions [22] or 100 WM diamide, which
oxidises sulfhydryl groups [23]. At the same time, the indicated con-
centrations of MEL, NAS and TX were added as a 500 mM stock
solution in ethanol, The ¢nal ethanol concentration was 0,1%. Pure
solvent (0.1% ethanol) was used as a negative control. After the in-
dicated time periods, the rhodamine £uorescence was analyzed at
488 nm/525 nm (excitation/emission) using a Becton-Dickinson
FACScan.
2.3. Determination of cell death
Cell death was monitored by means of the propidium iodide (PI)
uptake [24]. After 4 h of treatment with t-BHP and various concen-
trations of MEL and NAS, PBL were washed twice with an ice-cold
HEPES bu¡er (10 mM HEPES/NaOH, 140 mM NaCl, 2.5 mM
CaCl2, pH 7,4), 10 Wl of PI (50 Wg/ml) was added to the cell pellet
and incubated for 15 min at room temperature. The PI uptake, which
occurs in dead cells, was analyzed using a Becton-Dickinson FACS-
can at an emission wavelength of 600 nm.
2.4. Statistical analysis
A data analysis was performed by a repeated measures ANOVA
with a two factor repetition followed by a Tukey post-hoc test. The
analysis was done with the SigmaStat 2.03 Software package.
3. Results
3.1. Formation of rhodamine in the presence of MEL and NAS
in a cell-free system
In a cell-free system, we used 1 mM AAPH, which ther-
mally decomposes to yield peroxyl radicals at a constant rate,
as a ROS-generating system. Incubation of a solution of
DHR with 1 mM AAPH led to a time-dependent increase
of the rhodamine £uorescence (Fig. 1). Addition of MEL
led to a reduced rate of £uorescence generation, indicating
ine⁄cient scavenging of peroxyl radicals, however, its respec-
tive capacity was much lower than that of NAS. Fig. 1 shows
the relative e⁄ciency of MEL, NAS and TX in inhibiting the
peroxyl radical-induced oxidation of DHR. It is evident that
NAS at 10 WM was an even more e⁄cient radical scavenger
than TX at the same concentration, while MEL was compar-
atively weak in retarding the oxidation. Ethanol alone did not
a¡ect the DHR oxidation by peroxyl radicals.
3.2. MEL and NAS e¡ects on the intracellular DHR oxidation
in human PBL
Resting PBL showed almost no change in their spontaneous
intracellular ROS formation over a period of 4 h, as shown in
Fig. 2. Nevertheless, the content of intracellular ROS in these
cells can be reduced by the addition of TX and NAS. Inter-
estingly, while NAS had an e¡ect comparable to TX, MEL
did not decrease the intracellular ROS content. After 4 h of
incubation, even a slight enhancing e¡ect of MEL on the ROS
formation in resting PBL could be observed.
When PBL were incubated with the membrane-permeable
oxidant t-BHP (100 WM), which forms peroxyl- and alkoxyl
radicals [22], the intracellular rhodamine £uorescence showed
a time-dependent increase with a maximum after 2 h of in-
cubation (Fig. 3A). Addition of 1 mM MEL, NAS or TX,
respectively, reduced the DHR oxidation, indicating an anti-
oxidant e¡ect of all substances. However, the capacity of
MEL and NAS to scavenge t-BHP-induced ROS showed
marked di¡erences (Fig. 3B). While MEL signi¢cantly inhib-
ited the ROS formation in a concentration range of 100 WM^1
mM with a maximal inhibition of 44.5 þ 1.9% compared to
controls, NAS signi¢cantly decreased the DHR oxidation al-
ready at 30 WM with a maximal inhibition of 78.8 þ 0.9% at
1 mM, which is comparable to the antioxidant capacity of an
equimolar concentration of TX (Fig. 3A).
Incubation with the sulfhydryl-oxidizing agent diamide (100
WM) also induced an increase of the intracellular DHR oxi-
dation in PBL (Fig. 4) which was counteracted by MEL and
NAS. The lowest concentrations of MEL and NAS tested,
which showed an e¡ect, were 300 WM and 100 WM, respec-
tively. Maximal inhibition of the diamide-induced ROS for-
Fig. 1. E¡ects of MEL, NAS or TX on ROS formation in aqueous solution. 10 WM DHR in PBS was incubated at 37‡C and the rhodamine
£uorescence was monitored at 500 nm/560 nm (excitation/emission). Peroxyl radicals were generated by 1 mM AAPH and the e¡ect of 10 WM
TX, 10 WM and 1 mM MEL, 10 WM and 1 mM NAS on the DHR oxidation was monitored. All solutions contained 0.5% ethanol.
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mation by MEL (1 mM) and NAS (1 mM) was 54.1 þ 7.7%
and 84.0 þ 2.9%, respectively.
3.3. In£uence of MEL and NAS on the ROS-induced cell death
in human PBL
Since oxidants are known to induce lymphocyte cell death,
possibly by an apoptotic pathway [25], we investigated the
implications of the above described antioxidant features of
MEL and NAS on the t-BHP-mediated cell death in PBL.
As shown in Fig. 5, MEL as well as NAS were able to de-
crease the percentage of non-viable PBL after incubation with
t-BHP. However, 100 WM NAS but MEL only in concentra-
tions of more than 300 WM were e¡ective in protecting against
t-BHP-induced cell death and 100 WM NAS was as e¡ective as
1 mM MEL, indicating that MEL is by far less e⁄cient in
protecting PBL against oxidative stress than NAS.
4. Discussion
Since MEL and NAS can easily cross cell membranes due
to their amphiphilicity [26,27], we were interested to what
extent these indoleamines in£uence intracellular redox proc-
esses. Our results clearly point to a considerably higher ROS-
scavenging activity of NAS compared to that of MEL. In
terms of protective e¡ects against radical-induced cell death,
the di¡erence between NAS and MEL was even more pro-
nounced. While 300 WM NAS decreased the t-BHP-induced
cell death in PBL by 63%, the same concentration of MEL
only showed a reduction by 18%. Furthermore, 100 WM NAS
Fig. 2. E¡ects of MEL, NAS and TX on ROS formation in resting
human PBL. PBL (2U106 cells/ml) were loaded with 2 WM DHR
for 10 min at 37‡C. After washing with PBS, cells were resuspended
in RPMI (1U106 cells/ml) and incubated with the indicated concen-
trations of MEL, NAS, TX or solvent (0.1% ethanol in RPMI).
After the indicated time periods, the rhodamine £uorescence was
measured at 488 nm/525 nm (excitation/emission) using a Becton-
Dickinson FACScan. Data represent mean þ S.E.M., n = 4, each
done in triplicate.
C
Fig. 3. E¡ects of MEL, NAS and TX on ROS formation in t-BHP-
treated PBL. PBL (2U106 cells/ml) were loaded with 2 WM DHR
for 10 min at 37‡C. After washing with PBS, cells were resuspended
in RPMI (1U106 cells/ml). (a) Cells were left untreated or were in-
cubated with 100 WM t-BHP and 1 mM MEL, NAS, TX or solvent
(0.1% ethanol in RPMI). After the indicated time periods, the rhod-
amine £uorescence was measured at 488 nm/525 nm (excitation/
emission) using a Becton-Dickinson FACScan. Data represent
mean þ S.E.M., n = 4, each done in duplicate. (b) Cells were left un-
treated or were incubated with 100 WM t-BHP and the indicated
concentrations of MEL, NAS or solvent (0.1% ethanol in RPMI).
After 2 h of incubation, the rhodamine £uorescence was analyzed at
488 nm/525 nm (excitation/emission) using a Becton-Dickinson
FACScan. Data represent mean þ S.E.M., n = 3, each done in dupli-
cate.
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was as e¡ective as 1 mM MEL to protect PBL from ROS-
induced cell death. These results indicate that MEL exerts
only a little protective e¡ect against oxidative stress in cells
as compared to NAS.
Furthermore, in aqueous cell-free solutions, the capacity of
MEL to scavenge peroxyl radicals was much lower than that
of NAS. While 10 WM NAS was more e¡ective than the same
concentration of TX, MEL, even at millimolar concentra-
tions, had only minor e¡ects on the peroxyl radical-induced
DHR oxidation. This is in contrast to Pieri et al. [3], who
reported the capacity of MEL to scavenge AAPH-derived
peroxyl radicals to be twice that of TX. More recent studies,
however, are in line with our ¢ndings. MEL showed only a
weak protection of low density lipoproteins against oxidative
damage as compared to K-tocopherol [11] and a lack of anti-
oxidant activity of MEL against the peroxyl radical-induced
lipid peroxidation in model membranes has been demon-
strated recently [10]. According to Seegar et al. [15], who
also investigated e¡ects of MEL on the LDL oxidation, the
antioxidative activity of MEL was negligible compared to
other indoleamines, like serotonin, NAS and 6-hydroxymela-
nin. For serotonin, a higher e⁄ciency to prevent lipid peroxi-
dation than for MEL was reported [9]. A possible reason for
this di¡erence in their reactivity towards peroxyl radicals
Fig. 4. E¡ects of MEL, NAS and TX on ROS formation in di-
amide-treated PBL. PBL (2U106 cells/ml) were loaded with 2 WM
DHR for 10 min at 37‡C. After washing with PBS, cells were resus-
pended in RPMI (1U106 cells/ml). (a) Cells were left untreated or
were incubated with 100 WM diamide, which oxidizes sulfhydryl
groups, and 1 mM MEL, NAS, TX or solvent (0.1% ethanol in
RPMI). After the indicated time periods, the rhodamine £uorescence
was measured at 488 nm/525 nm (excitation/emission) using a Bec-
ton-Dickinson FACScan. Data represent mean þ S.E.M., n = 4, each
done in duplicate. (b) Cells were left untreated or were incubated
with 100 WM diamide and the indicated concentrations of MEL,
NAS or solvent (0.1% ethanol in RPMI). After 2 h of incubation,
the rhodamine £uorescence was measured at 488 nm/525 nm (excita-
tion/emission) using a Becton-Dickinson FACScan. Data represent
mean þ S.E.M., n = 3, each done in duplicate.
6
Fig. 5. The in£uence of MEL and NAS on the t-BHP-induced cell
death in PBL. PBL (1U106 cells/ml) were left untreated or were in-
cubated with 100 WM t-BHP and the indicated concentrations of
MEL, NAS or solvent (0.1% ethanol in RPMI). After 4 h of treat-
ment, PBL were washed twice with ice-cold HEPES bu¡er and incu-
bated with PI (10 Wg/ml) for 15 min at room temperature. The per-
centage of PI positive cells was determined using a Becton-
Dickinson FACScan at an emission wavelength of 600 nm. Data
represent mean þ S.E.M. of one experiment out of three giving iden-
tical results, n = 3, each done in duplicates.
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might be the phenolic OH-group in NAS and serotonin which
is absent in MEL.
Although pinealectomy in rats, which abolishes circulating
levels of MEL, has been reported to exaggerate the oxidative
damage after treatment of rats with ROS-generating agents
[28], the physiological signi¢cance of its antioxidant activity,
which is observed only at micromolar concentrations, remains
questionable, since the nocturnal peak serum concentration of
MEL in humans as well as in other mammals is in the pico-
molar range [29]. Beside its endocrine release from the pineal
gland, MEL was suggested to be produced and released by
human PBL [30] as well as by cultured skin cells [31], indicat-
ing a paracrine or intracellular role as well. However, the
concentrations of paracrine and intracellular MEL in lym-
phoid tissues or in the skin are not yet known.
In human serum, NAS is found in nanomolar concentra-
tions [32], which are about 10^100-fold higher than MEL and
NAS is produced and released by cultured skin cells [31] and
by human PBL [30]. In skin cells, the amount of released NAS
after serotonin addition was about 10 times higher than that
of MEL. Furthermore, NAS is a major product of the in vivo
back-transformation of MEL in various tissues [33], including
human PBL [34]. Therefore, the concentration of NAS in
various tissues is presumably much higher than that of
MEL. This issue has to be clari¢ed in further studies.
Our ¢nding that MEL, in contrast to NAS and TX, is not
able to decrease the intracellular ROS formation in resting
PBL, but even led to a slight increase, points to a qualitative
di¡erence between MEL and NAS in in£uencing intracellular
redox processes. This notion is corroborated by ¢ndings that
MEL enhances the ROS formation in resting Jurkat cells, a
human leukemic cell line, while NAS reduced it [35] and by
Barsacchi et al. [36] reporting that vitamin E consumption in
erythrocytes exposed to oxidative stress was reduced by NAS
but enhanced by MEL.
Our results in a biochemical and a cellular experimental
system demonstrate that NAS, the immediate precursor of
MEL, is a better antioxidant than MEL itself. NAS exhibited
antioxidative e¡ects at 3^10-fold lower concentrations than
MEL. Together with the fact that extracellular and intracel-
lular NAS concentrations in vivo are considerably higher than
those of MEL, these results clearly indicate NAS to be a
physiologically more relevant antioxidant. Thus, an outstand-
ing role of MEL as well as its physiological signi¢cance as
anti-ageing principle due to its antioxidative features has to be
questioned.
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